Natco Pharma Ltd. | Balance Sheet

Fiscal year is April-March. All values INR Millions.
2014
2015
2016
2017
2018
2019
Cash & Short Term Investments
114
135
1,073
1,372
2,521
4,282
Total Accounts Receivable
1,213
1,943
2,833
4,971
6,827
5,133
Inventories
1,936
2,304
3,669
3,695
4,577
5,290
Other Current Assets
418
448
795
835
7,382
8,767
Total Current Assets
3,681
4,830
8,370
10,873
21,307
23,472
Net Property, Plant & Equipment
7,365
7,930
9,600
11,988
15,502
18,561
Total Investments and Advances
76
86
37
56
139
364
Long-Term Note Receivable
6
-
6
5
5
20
Intangible Assets
320
459
55
58
59
87
Other Assets
509
535
149
196
139
527
Total Assets
11,957
13,840
18,277
23,186
37,158
43,031
ST Debt & Current Portion LT Debt
1,507
2,148
1,126
2,216
1,732
Accounts Payable
1,077
1,331
2,756
2,627
2,691
Income Tax Payable
13
2
34
133
26
Other Current Liabilities
526
656
1,015
1,289
1,471
Total Current Liabilities
3,123
4,137
4,931
6,265
5,920
Long-Term Debt
955
970
-
-
-
Provision for Risks & Charges
111
95
125
219
324
Deferred Taxes
431
119
147
150
139
Other Liabilities
10
8
8
8
8
Total Liabilities
4,630
5,330
5,271
6,652
6,398
Common Equity (Total)
7,259
8,461
12,957
16,493
30,722
Total Shareholders' Equity
7,259
8,461
12,957
16,493
30,722
Total Equity
7,328
8,511
13,006
16,534
30,760
Liabilities & Shareholders' Equity
11,957
13,840
18,277
23,186
37,158
Accumulated Minority Interest
69
50
49
41
38

About Natco Pharma

View Profile
Address
NATCO House
Hyderabad TS 500034
India
Employees -
Website http://www.natcopharma.co.in
Updated 07/08/2019
NATCO Pharma Ltd. engages in the business of pharmaceuticals which comprises research and development, manufacturing and selling of bulk drugs and finished dosage formulations. It operates through the following segments: Domestic Formulations, International Formulations, and Active Pharmaceutical Ingredients. The Domestic Formulations is a leading player in India's oncology segment with 28 active brands.